Featured Press – n-Lorem

BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome

ReNU syndrome was discovered [...]

Andrew Andrew Serrano2026-07-26T21:12:06-04:00

Impressive Benefits and an Excellent Safety and Tolerability Profiles in Two Severely Affected Patients With Mutations in a Vital Sodium Channel (SCN2A) Treated With Bespoke ASOs Reported in Nature Medicine

n-Lorem discovered, developed and provided [...]

Andrew Andrew Serrano2026-07-21T13:46:39-04:00

Servier and n-Lorem Foundation Join Forces to Advance Research in Rare Neurodevelopmental Disorders

Partnership will combine n-Lorem's cutting-edge [...]

Nate Velasco2026-07-26T21:15:37-04:00